Catalent Acquires Majority of Chinese Softgel Business

Having met the required regulatory approvals, Catalent Pharma Solutions, Somerset, NJ, has completed the acquisition of a majority share in Haining-based, privately held Zhejiang Jiang Yuan Tang Biotechnology Co., Ltd. The business produces nutritional softgel products for Chinese and Asia Pacific markets, and employs 120 staff. 
 
Catalent plans to initially concentrate on the growing vitamins, minerals and supplements market in Asia-Pacific, whilst simultaneously investing in its facilities and working with regulators to expand their business into OTC and prescription softgel manufacturing for the region. Additionally, the company has announced the appointment of Mr. Weiyan “Jackson” Zhu as Country general manager for China.